Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.
Following the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.
Comments